Forrester Opens Nominations For Its 2025 Customer Obsession Awards
Awards recognize companies and leaders that align their organizational efforts around customers’ needs and deliver seamless experiences across channels
Forrester (Nasdaq: FORR) today opened the call for nominations for its 2025 Customer-Obsessed Enterprise Awards. Open to organizations headquartered in Asia Pacific, Europe, and North America with 1,000 or more employees, these awards recognize companies that prioritize customers in their leadership, strategy, and operations to drive successful business outcomes. Applications for Forrester’s Customer-Obsessed Leadership Award are also open to senior B2C marketing, customer experience (CX), and digital business leaders at organizations headquartered in North America with 1,000 or more employees.
Nomination criteria for Forrester’s Customer Obsession Awards are as follows:
- Customer-Obsessed Enterprise. This award honors an organization that exemplifies customer obsession by prioritizing customers in their leadership, corporate and functional strategies, and daily operations to drive successful business outcomes. The winning organization also encourages deep collaboration across the business — especially among marketing, CX, and digital teams — to ensure that customer obsession is achieved.
- Customer-Obsessed Leadership. This award recognizes a leader who behaves and makes decisions with a focus on customers. The winning executive also creates a workplace environment conducive to great customer focus for the entire organization.
Additional details on how to apply for Forrester’s 2025 Customer Obsession Awards:
- Europe. Organizations based in EMEA can visit here to review complete award nomination criteria and submit an entry for Forrester’s Customer-Obsessed Enterprise Awards. The deadline to submit an entry is March 31, 2025. The award recipient will be announced prior to and honored at Forrester’s CX Summit EMEA, taking place June 2–4, 2025.
- North America. Organizations and leaders based in North America can visit here to learn more. The submission deadline is March 31, 2025 for both Forrester’s Customer-Obsessed Enterprise and Customer-Obsessed Leadership Awards. Award recipients will be announced prior to and honored at Forrester’s CX Summit North America, taking place June 23–26, 2025.
- Asia Pacific. Organizations based in APAC can visit here to review complete award nomination criteria and submit an entry for Forrester’s Customer-Obsessed Enterprise Awards. The deadline to submit an entry is May 23, 2025. The award recipient will be announced prior to and honored at Forrester’s CX Summit APAC, taking place August 18, 2025.
“Forrester’s Customer Obsession Awards will recognize organizations and leaders that show how their dedication and focus on their customers also yields stronger outcomes for their business,” said Rick Parrish, vice president and research director at Forrester. “Our research finds that customer-obsessed organizations report 41% faster revenue growth, 49% faster profit growth, and 51% better customer retention than non-customer-obsessed organizations. As true customer obsession is achieved, so too is sustainable growth for organizations.”
Resources:
- Learn more about Forrester’s Customer Obsession Awards program and previous award winners.
- Register to attend Forrester’s 2025 APAC, EMEA, and North America CX Summits.
About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We empower leaders in technology, customer experience, digital, marketing, sales, and product functions to be bold at work and accelerate growth through customer obsession. Our unique research and continuous guidance model helps executives and their teams achieve their initiatives and outcomes faster and with confidence. To learn more, visit Forrester.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250127397273/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom